Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia

Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

NCT02280902 ·Status: COMPLETED

Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)

NCT02243228 ·Status: UNKNOWN ·Phase: PHASE2

NETs Formation in Patients With Recurrent Pyogenic Infections (NETS)

NCT01112592 ·Status: UNKNOWN

Hyperimmune Plasma for Patients With COVID-19

NCT04614012 ·Status: UNKNOWN ·Phase: NA

Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study

NCT06614998 ·Status: RECRUITING

An Extention Study of Safety of Canakinumab in Japanese Patients With Periodic Fever Syndromes

NCT02911857 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Wegener's Granulomatosis With Cyclophosphamide

NCT00001155 ·Status: COMPLETED ·Phase: PHASE2

GM-CSF in Patients With Pulmonary Alveolar Proteinosis

NCT00030056 ·Status: TERMINATED ·Phase: PHASE2

Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy

NCT00302510 ·Status: COMPLETED ·Phase: NA

Sequential Therapy With WLL/Inhaling GM-CSF for Autoimmune Pulmonary Alveolar Proteinosis

NCT03316651 ·Status: UNKNOWN ·Phase: PHASE2

Mobile App-Based Infection Monitoring in Familial Mediterranean Fever

NCT07212764 ·Status: ENROLLING_BY_INVITATION

Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)

NCT01862068 ·Status: COMPLETED

Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen

NCT03009708 ·Status: COMPLETED ·Phase: NA

Non Randomized Comparative Study With Control

NCT03294824 ·Status: UNKNOWN

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

NCT00001764 ·Status: COMPLETED ·Phase: PHASE1

Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides

NCT00001473 ·Status: COMPLETED

To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

NCT00302549 ·Status: COMPLETED ·Phase: NA

Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes

NCT00004567 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19

NCT06968156 ·Status: COMPLETED

Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome.

NCT04585152 ·Status: UNKNOWN ·Phase: PHASE2

Steroids and Methotrexate to Treat Systemic Vasculitis

NCT00001256 ·Status: COMPLETED ·Phase: PHASE2

Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis

NCT02910258 ·Status: COMPLETED

Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)

NCT06983821 ·Status: RECRUITING ·Phase: PHASE3

Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study

NCT06009042 ·Status: UNKNOWN ·Phase: PHASE4

Short-term Glucocorticoid Combined with MMF for IgG4-RD

NCT06663618 ·Status: RECRUITING ·Phase: NA